Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Immunotherapy for Alzheimer's disease
Michael Steinitz
*
*
Corresponding author for this work
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunotherapy for Alzheimer's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Anti-A
100%
Alzheime's Disease
100%
Alzheimer Patients
100%
Homeostasis
66%
Alzheimer's Disease Model
66%
Passive Vaccination
66%
Healthy Individuals
33%
Monoclonal Antibody
33%
Cognitive Impairment
33%
Clinical Trials
33%
Murine Model
33%
IgG Antibody
33%
Catabolic
33%
Commercial Preparations
33%
IgM Antibody
33%
Active Immunization
33%
Amyloid Precursor Protein
33%
Intravenous Immunoglobulin (IVIg)
33%
Safety Issues
33%
Passive Immunization
33%
Cognitive Improvement
33%
Immunology and Microbiology
Immunotherapy
100%
Alzheimer's Disease
100%
Blood Group A Antibody
37%
Homeostasis
25%
Precursor
12%
Normal Human
12%
Intravenous Immunoglobulin
12%
Monoclonal Antibody
12%
Immunoglobulin M
12%
Immunoglobulin G
12%
Neuroscience
Alzheimer's Disease
100%
Immunotherapy
100%
Blood Group A Antibody
37%
Intravenous Immunoglobulin
12%
Monoclonal Antibody
12%
Amyloid Precursor Protein
12%
Immunoglobulin M
12%
Amyloid Protein
12%
Immunoglobulin G
12%